Jul 22, 2025 / 07:00AM GMT
Fredrik Dahl - Devyser Diagnostics AB - Acting Chief Executive Officer, Director
Good day and welcome to the visor Q2 2025 earnings call. I'm Fredrik Dahl. I'm the acting CEO of Devyser and would like to thank you everyone for joining our call today.
On the call today, we have, in addition to myself, also our CFO, Sabina Berlin; and our Chief Commercial Officer, Theis Kipling.
I will start with a short summary of our quarterly results and then recap our recent activities that have resulted in an improved efficiency overall for the organization. I will then give an update on the recent product launches and present some additional highlights from the quarter before handing over to Sabina for a more detailed review of our financial results in Q2 2025, and then to tie for an update on our recent commercial activities.
We are turning the company around on a path to profitability. We had another record quarter based on revenue with SEK67 million second sales representing a growth of around 27% compared to Q2 last year. Gross margins came in at 84%. What we are most proud of is the
Q2 2025 Devyser Diagnostics AB Earnings Call Transcript
1 day ago
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers